EFFECT OF PREOPERATIVE INTRAVENOUS STERIODS ON SEROMA FORMATION AFTER MODIFIED RADICAL MASTECTOMY
AbstractBackground: With the steep increase in breast cancer incidence globally and regionally, there has been a trend toward reducing patient morbidity by meticulous surgical techniques to obviate complications like seroma formation; use to pre-operative steroids seems to be convenient, cost effective and shows promising results in trials. Methods: This randomized clinical trial was conducted at Surgical Department of Khyber Teaching Hospital Peshawar, from January 2012 to April 2014 on 65 patients randomly allocated to Group A and Group B using lottery method. Group A underwent MRM+AD in the conventional manner while Group B received a 120 mg of injection Depomedrol intravenously 1 hour before the surgery. The two were compared in terms of total drainage, days of drainage, wound complications and incidence of seroma. Data was entered and analysed using statistical program SPSS-21. Results: The mean age in group A was 34.2±10.1 years and B was 32.3±9.1 years. The mean drainage in intervention group was significantly reduced as compared to control group (755.4±65ml vs 928.3±102.5). Total drainage days were reduced (6.5±1.6 days vs 10.2±2.2 days) and incidence of seroma was also reduced (A=18.75% vs B=6.06%). However, three patients in group B had wound infection. Conclusions: Seroma formation is the most common complication of Mastectomy and among the methods used to reduce its incidence, steroid administration seems to be the most cost effective and shows promising results.Keywords: Mastectomy; Modified Radical Mastectomy; Methylprednisolone; Seroma Formation
DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin 2014;64(1):52–62.
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013;49(6):1374–403.
Shaukat U, Ismail M, Mehmood N. Epidemiology, major risk factors and genetic predisposition for breast cancer in the Pakistani population. Asian Pac J Cancer Prev 2013;14(10):5625–9.
Rasheed R. Breast cancer. J Coll Physicians Surg Pak 2013;23(10):766–7.
Hadi N, Soltanipour S, Talei A. Impact of modified radical mastectomy on health-related quality of life in women with early stage breast cancer. Arch Iran Med 2012;15(8):504–7.
Wedgwood KR, Benson EA. Non-tumor morbidity and mortality after modified radical mastectomy. Ann Royal Coll Surg Engl 1992;74(5):314–7.
Sampathraju S, Rodrigues G. Seroma formation after mastectomy: pathogenesis and prevention. Indian J Surg Oncol 2010;1(4):328–33.
Gong Y, Xu J, Shao J, Cheng H, Wu X, Zhao D, et al. Prevention of seroma formation after mastectomy and axillary dissection by lymph vessel ligation and dead space closure: a randomized trial. Am J Surg 2010;200(3):352–6.
Ribeiro GH, Kerr LM, Haikel RL, Peres SV, Matthes AG, Depieri Michelli RA, et al. Modified radical mastectomy: a pilot clinical trial comparing the use of conventional electric scalpel and harmonic scalpel. Int J Surg 2013;11(6):496–500.
Ozaslan C, Yilmaz KB, Doğan I, Atalay C, Altinok M. Effect of mechanical closure of dead space on seroma formation in modified radical mastectomy. Turk J Med Sci 2010;40(5):751–5.
Wolde B, van den Wildenberg FJ, Keemers-Gels ME, Polat F, Strobbe LJ. Quilting Prevents seroma formation following breast cancer surgery: closing the dead space by quilting prevents seroma following axillary lymph node dissection and mastectomy. Ann Surg Oncol 2014;21(3):802–7.
Sakkary MA. The value of mastectomy flap fixation in reducing fluid drainage and seroma formation in breast cancer patients. World J Surg Oncol 2012;10:8.
Yenidogan E, Akgul GG, Gulcelik MA, Dinc S, Colakoglu MK, Kayaoglu HA. Effect of beta-glucan on drain fluid and amount of drainage following modified radical mastectomy. Adv Ther 2014;31(1):130–9.
Bonnema J, Ligtenstein DA, Wiggers T, van geel AN. The composition of serous fluid after axillary dissection. Eur J Surg 1999;165(1):9–13.
Watt-Boolsen S, Nielsen VB, Jensen J, Bak S. A study of the nature and origin of seroma after mastectomy. Dan Med Bull 1989;36(5):487–9.
Aitken DR, Minton JP. Complications associated with mastectomy. Surg Clin North Am 1983;63(6):1331–52.
Szecsi PB, Larsen J, Hørby J, Axelsson CK. Seroma Production after Breast Cancer Surgery has a Pro-Inflammatory Component. Open Breast Cancer J 2012;4(1):11–7.
Axelsson CK, Quamme GM, Lanng C, Szecsi PB, Mortensen MB, Wegeberg B, et al. Local injection of methylprednisolonacetate to prevent seroma formation after mastectomy. Dan Med J 2012;59(9):A4482.
Qvamme G, Axelsson CK, Lanng C, Mortensen M, Wegeberg B, Okholm M, et al. Randomized clinical trial of prevention of seroma formation after mastectomy by local methylprednisolone injection. Br J Surg 2015;102(10):1195–203.
Taghizadeh R, Shoaib T, Hart AM, Weiler-Mithoff EM. Triamcinolone reduces seroma reaccumulation in the extended latissimus dorsi donor site. J Plast Reconstr Aesthet Surg 2008;61(6):636–42.
Turel KS, Dilek ON, Akbulut G, Sahin DA, Ozenc E, Yazicioglu MB. Effects of local anti-inflammatory drugs on seroma formation after mastectomy and axillary lymph node dissection in the rat model. Natl J Med Res 2014;4(3):228–31.